You have accessJournal of UrologyImaging/Radiology: Uroradiology II (MP42)1 Apr 2020MP42-11 AN INTERNATIONAL CHALLENGE TO USE ARTIFICIAL INTELLIGENCE TO DEFINE THE STATE OF THE ART IN KIDNEY AND KIDNEY TUMOR SEGMENTATION IN CT IMAGING Nicholas Heller, Sean McSweeney*, Matthew Peterson, Sarah Peterson, Jack Rickman, Bethany Stai, Resha Tejpaul, Makinna Oestreich, Paul Blake, Joel Rosenberg, Keenan Moore, Edward Walczak, Zachary Edgerton, Ranveer Vasdev, Arveen Kalapara, Niranjan Sathianathen, Nikolaos Papanikolopoulos, and Christopher Weight Nicholas HellerNicholas Heller More articles by this author , Sean McSweeney*Sean McSweeney* More articles by this author , Matthew PetersonMatthew Peterson More articles by this author , Sarah PetersonSarah Peterson More articles by this author , Jack RickmanJack Rickman More articles by this author , Bethany StaiBethany Stai More articles by this author , Resha TejpaulResha Tejpaul More articles by this author , Makinna OestreichMakinna Oestreich More articles by this author , Paul BlakePaul Blake More articles by this author , Joel RosenbergJoel Rosenberg More articles by this author , Keenan MooreKeenan Moore More articles by this author , Edward WalczakEdward Walczak More articles by this author , Zachary EdgertonZachary Edgerton More articles by this author , Ranveer VasdevRanveer Vasdev More articles by this author , Arveen KalaparaArveen Kalapara More articles by this author , Niranjan SathianathenNiranjan Sathianathen More articles by this author , Nikolaos PapanikolopoulosNikolaos Papanikolopoulos More articles by this author , and Christopher WeightChristopher Weight More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000891.011AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE:The 2019 Kidney and Kidney Tumor Segmentation challenge (KiTS19) was an international competition held in conjunction with the 2019 International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) and sought to stimulate progress on this automatic segmentation frontier. Growing rates of kidney tumor incidence led to research into the use of artificial inteligence (AI) to radiographically differentiate and objectively characterize these tumors. Automated segmentation using AI objectively quantifies complexity and aggression of renal tumors to better differentiate and describe the tumors for improved treatment decision making. METHODS: A training set of over 31,000 CT images from 210 patients with kidney tumors was publicly released with corresponding semantic segmentation masks. 106 teams from five continents used this data to develop automated deep learning systems to predict the true segmentation masks on a test set of an additional 13,500 CT images in 90 patients for which the corresponding ground truth segmentations were kept private. These predictions were scored and ranked according to their average Sørensen-Dice coefficient between kidney and tumor across the 90 test cases. RESULTS: The winning team achieved a Dice of 0.974 for kidney and 0.851 for tumor, approaching the human inter-annotator performance on kidney (0.983) but falling short on tumor (0.923). This challenge has now entered an “open leaderboard” phase where it serves as a challenging benchmark in 3D semantic segmentation. CONCLUSIONS: Results of the KiTS19 challenge show deep learning methods are fully capable of reliable segmentation of kidneys and kidney tumors. The KiTS19 challenge attracted a high number of submissions and serves as an important and challenging benchmark in 3D segmentation. The publicly available data will further propel the use of automated 3D segmentation analysis. Fully segmented kidneys and tumors allow for automated calculation of all types of nephrometry, tumor textural variation and discovery of new predictive features important for personalized medicine and accurate prediction of patient relevant outcomes. Source of Funding: Research reported in this abstract was supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA225435. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e607-e607 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nicholas Heller More articles by this author Sean McSweeney* More articles by this author Matthew Peterson More articles by this author Sarah Peterson More articles by this author Jack Rickman More articles by this author Bethany Stai More articles by this author Resha Tejpaul More articles by this author Makinna Oestreich More articles by this author Paul Blake More articles by this author Joel Rosenberg More articles by this author Keenan Moore More articles by this author Edward Walczak More articles by this author Zachary Edgerton More articles by this author Ranveer Vasdev More articles by this author Arveen Kalapara More articles by this author Niranjan Sathianathen More articles by this author Nikolaos Papanikolopoulos More articles by this author Christopher Weight More articles by this author Expand All Advertisement PDF downloadLoading ...
Read full abstract